Total Payments
$1.1M
2024 Payments
$204,771
Companies
37
Transactions
1,991
Medicare Patients
320
Medicare Billing
$48,792
Payment Breakdown by Category
Other$776,921 (72.5%)
Travel$146,225 (13.6%)
Consulting$115,732 (10.8%)
Food & Beverage$32,818 (3.1%)
Education$322.03 (0.0%)
Gifts$20.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $645,524 | 294 | 60.2% |
| Travel and Lodging | $146,225 | 612 | 13.6% |
| Consulting Fee | $115,732 | 31 | 10.8% |
| Honoraria | $98,374 | 50 | 9.2% |
| Compensation for serving as faculty or as a speaker for a medical education program | $33,023 | 16 | 3.1% |
| Food and Beverage | $32,818 | 982 | 3.1% |
| Education | $322.03 | 5 | 0.0% |
| Gift | $20.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | $379,320 | 508 | $0 (2024) |
| IRONSHORE PHARMACEUTICALS INC. | $186,679 | 301 | $0 (2024) |
| Shire North American Group Inc | $69,647 | 196 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $61,508 | 133 | $0 (2024) |
| ABBVIE INC. | $58,046 | 89 | $0 (2024) |
| Tris Pharma Inc | $57,104 | 129 | $0 (2024) |
| Neos Therapeutics, LP | $49,807 | 63 | $0 (2021) |
| Corium, LLC | $40,909 | 54 | $0 (2024) |
| Noven Pharmaceuticals, Inc. | $37,627 | 30 | $0 (2024) |
| Rhodes Pharmaceuticals L.P. | $34,693 | 63 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $204,771 | 273 | Supernus Pharmaceuticals, Inc. ($87,284) |
| 2023 | $189,187 | 253 | Supernus Pharmaceuticals, Inc. ($94,010) |
| 2022 | $131,603 | 202 | Supernus Pharmaceuticals, Inc. ($87,797) |
| 2021 | $52,173 | 85 | Supernus Pharmaceuticals, Inc. ($36,093) |
| 2020 | $53,596 | 124 | Supernus Pharmaceuticals, Inc. ($21,693) |
| 2019 | $193,107 | 413 | Ironshore Pharmaceuticals Inc. ($124,135) |
| 2018 | $103,426 | 310 | Tris Pharma Inc ($22,792) |
| 2017 | $144,175 | 331 | Shire North American Group Inc ($61,900) |
All Payment Transactions
1,991 individual payment records from CMS Open Payments — Page 1 of 80
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $24.43 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/06/2024 | Tris Pharma Inc | Onyda XR (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: ADHD | ||||||
| 12/06/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $8.73 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 12/01/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/01/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $5.66 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/23/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $22.68 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $122.03 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Honoraria | Cash or cash equivalent | $5,990.00 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Travel and Lodging | In-kind items and services | $547.95 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Travel and Lodging | In-kind items and services | $530.00 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Travel and Lodging | In-kind items and services | $280.80 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Travel and Lodging | In-kind items and services | $250.73 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $125.21 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Travel and Lodging | In-kind items and services | $20.00 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $6.67 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $27.01 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/01/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: ADHD | ||||||
| 10/24/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: Neuroscience | ||||||
| 10/21/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $7.76 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: PSYCHIATRY | ||||||
| 10/18/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $15.36 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 10/16/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $9.83 | General |
| Category: CNS Stimulant for ADHD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 59 | 216 | $25,720 | $10,982 |
| 2022 | 2 | 73 | 244 | $25,280 | $11,137 |
| 2021 | 3 | 86 | 295 | $30,300 | $14,462 |
| 2020 | 3 | 102 | 275 | $28,405 | $12,212 |
Total Patients
320
Total Services
1,030
Medicare Billing
$48,792
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 59 | 216 | $25,720 | $10,982 | 42.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 61 | 222 | $22,200 | $9,588 | 43.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 22 | $3,080 | $1,549 | 50.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 61 | 244 | $24,400 | $11,775 | 48.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 13 | 20 | $2,800 | $1,384 | 49.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 12 | 31 | $3,100 | $1,303 | 42.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 66 | 224 | $22,400 | $9,308 | 41.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 22 | 26 | $3,640 | $1,856 | 51.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 14 | 25 | $2,365 | $1,047 | 44.3% |
About Dr. Birgit Amann, M.D
Dr. Birgit Amann, M.D is a Child & Adolescent Psychiatry healthcare provider based in Troy, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386663789.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Birgit Amann, M.D has received a total of $1.1M in payments from pharmaceutical and medical device companies, with $204,771 received in 2024. These payments were reported across 1,991 transactions from 37 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($645,524).
As a Medicare-enrolled provider, Amann has provided services to 320 Medicare beneficiaries, totaling 1,030 services with total Medicare billing of $48,792. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Child & Adolescent Psychiatry
- Location Troy, MI
- Active Since 07/18/2006
- Last Updated 07/03/2023
- Taxonomy Code 2084P0804X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1386663789
Products in Payments
- QELBREE (Drug) $181,890
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $124,135
- Qelbree (Drug) $87,284
- MYDAYIS (Drug) $63,587
- JORNAY PM (Drug) $62,544
- REXULTI (Drug) $62,028
- VRAYLAR (Drug) $58,693
- Adzenys XR-ODT (Drug) $49,807
- Dyanavel XR (Drug) $48,099
- Xelstrym (Drug) $37,688
- Aptensio XR (Drug) $34,693
- Auvelity (Drug) $33,723
- Azstarys (Drug) $25,200
- Trintellix (Drug) $20,938
- AZSTARYS (Drug) $15,709
- ADHANSIA XR (Drug) $13,677
- Quillichew ER (Drug) $4,600
- SPRAVATO (Drug) $4,551
- TROKENDI XR (Drug) $4,519
- Quillivant (Drug) $3,000
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Child & Adolescent Psychiatry Doctors in Troy
Brooke Weingarden, Do Mph And/Or Pllc, DO MPH AND/OR PLLC
Child & Adolescent Psychiatry — Payments: $134.47
Child & Adolescent Psychiatry $134.47
Sravanthi Pajerla, M.d, M.D
Child & Adolescent Psychiatry — Payments: $102.01
Child & Adolescent Psychiatry $102.01
Dr. Marilyn Hamer, M.d, M.D
Child & Adolescent Psychiatry — Payments: $56.14
Child & Adolescent Psychiatry $56.14
Jeffrey London, Md, MD
Child & Adolescent Psychiatry
Child & Adolescent Psychiatry
Dr. Kristine Roth, Md, MD
Child & Adolescent Psychiatry
Child & Adolescent Psychiatry
Salma Brinjikji, Do, DO
Child & Adolescent Psychiatry
Child & Adolescent Psychiatry